SERNOVA BIOTHERAPEUTICS INC.

Profile

Company Names

SERNOVA BIOTHERAPEUTICS INC.

Addresses

PO 29592 RPO CENTRAL PARKWAY, MISSISSAUGA, A6 L5A4H2

Phone Numbers

(416) 457-4670

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

ONTARIO, CANADA

Total Amount Raised:

$344,514.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2025-10-31 
$344,514.00 
$843,153.00 
$498,639.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
 
BROOKS 
DIRECTOR
UPTAKE MEDICAL CORP   |  NOXILIZER INC   |  THERMALIN DIABETES, LLC   |  HYGIEIA INC   |  THERMALIN INC.   |  AMMONETT PHARMA LLC   |  CROCKETT PARTNERS FUND I, LP   |  THEROMICS INC.   |  POINT 406 VENTURES V, L.P.   |  ALERTGY INC.   |  ALTRIXBIO, INC.   |  SERNOVA BIOTHERAPEUTICS INC.
DAVID 
 
BURKE 
EXECUTIVE OFFICER
GNS HEALTHCARE, INC.   |  HEY WORDY, LLC   |  MAKENA STRATEGIC OPPORTUNITIES FUND KANDLE, L.P.   |  SELBY LANE PRIVATE EQUITY CUSTOM ACCOUNTS HEALTHCARE SPV II   |  SERNOVA BIOTHERAPEUTICS INC.
TANYA 
 
LEWIS 
DIRECTOR
SERNOVA BIOTHERAPEUTICS INC.
BERND 
 
MUEHLENWEG 
DIRECTOR
SERNOVA CORP.   |  SERNOVA BIOTHERAPEUTICS INC.
JAMES 
 
PARSONS 
EXECUTIVE OFFICER
AMORFIX LIFE SCIENCES LTD   |  JSI HOLDING CORP.   |  HASTINGS HOLDING CORP.   |  CARLISLE COUNTRY CLUB   |  JUNTO CAPITAL PARTNERS LP   |  SERNOVA CORP.   |  ECHO ENERGY PLC   |  TRILLIUM THERAPEUTICS INC.   |  DIAMEDICA THERAPEUTICS INC.   |  JUNTO CAPITAL AFFILIATES LP   |  SERNOVA BIOTHERAPEUTICS INC.
DAVID 
 
PATERSON 
DIRECTOR
PLEDGEPLATFORM, LLC   |  SERNOVA BIOTHERAPEUTICS INC.
JONATHAN 
 
RIGBY 
EXECUTIVE OFFICER, DIRECTOR
STEADYMED LTD.   |  XERIS PHARMACEUTICALS INC   |  SERNOVA CORP.   |  SERNOVA BIOTHERAPEUTICS INC.
MARYLYN 
 
RIGBY 
EXECUTIVE OFFICER
SERNOVA BIOTHERAPEUTICS INC.
STEVEN 
 
SANGHA 
DIRECTOR
BLOCKCHAINK2 CORP   |  SERNOVA CORP.   |  SERNOVA BIOTHERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-02-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#